Inventia Life Science Revenue and Competitors

Alexandria,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Inventia Life Science's estimated annual revenue is currently $15.7M per year.(i)
  • Inventia Life Science's estimated revenue per employee is $155,000

Employee Data

  • Inventia Life Science has 101 Employees.(i)
  • Inventia Life Science grew their employee count by -17% last year.

Inventia Life Science's People

NameTitleEmail/Phone
1
Head Life ScienceReveal Email/Phone
2
Head PeopleReveal Email/Phone
3
Head Supply Chain OperationsReveal Email/Phone
4
Head Product - LigoReveal Email/Phone
5
Head FinanceReveal Email/Phone
6
Head Manufacturing OperationsReveal Email/Phone
7
Commercial Director EuropeReveal Email/Phone
8
Chief Product OfficerReveal Email/Phone
9
Product Marketing ManagerReveal Email/Phone
10
Senior Go-To-Market Strategy and Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Inventia Life Science?

Inventia Life Science is advancing 3D bioprinting technology to revolutionise biomedical research and regenerative medicine. The company's strong foundation of fundamental research has led to the development of a proprietary platform encompassing bioprinting technology, an expanding library of printable bioink materials and custom protocols for specific applications. The RASTRUM platform is now available to enable efficient and powerful bioprinting of 3D cell-based assays for biomedical research.

keywords:N/A

N/A

Total Funding

101

Number of Employees

$15.7M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.2M101-6%N/A
#2
$17.9M1029%N/A
#3
$7.5M10317%N/A
#4
$18.7M1041%N/A
#5
$32.3M105-15%N/A